GGrantIndex
← Leaderboards

Cheng Wang

University Of Nebraska Medical Center

$7,992,551
Attributed
$7,992,551
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $981K · FY201025
$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,992,551 · 5

By mechanism

R01$7,096,995 · 3
R00$715,556 · 1
K99$180,000 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Epithelial Cells

Research focus

Epithelial CellsPlayPathway InteractionsDesignIn VitroAchievementMalignant Neoplasm Of OvaryCellsMolecularSignal PathwayTransgenic MicePreventionSignal TransductionMouse ModelDiagnosisPublic Health RelevanceCarcinogenesisOvaryBaseOvarianMalignant NeoplasmsCell ProliferationEtiologyCancer Cell

Grant awards (26)

Role of the YAP1-LATS2 negative feedback loop in cervical carcinogenesis$487,215
R01 · FY2025 · CA · contact PI
The Hippo Signaling Pathway in High Grade Serous Ovarian Carcinoma$404,401
R01 · FY2025 · CA · contact PI
Role of the YAP1-LATS2 negative feedback loop in cervical carcinogenesis$408,611
R01 · FY2024 · CA · contact PI
The Hippo Signaling Pathway in High Grade Serous Ovarian Carcinoma$384,181
R01 · FY2024 · CA · contact PI
Role of the YAP1-LATS2 negative feedback loop in cervical carcinogenesis$419,573
R01 · FY2023 · CA · contact PI
The Hippo Signaling Pathway in High Grade Serous Ovarian Carcinoma$376,073
R01 · FY2023 · CA · contact PI
The Hippo Signaling Pathway in High Grade Serous Ovarian Carcinoma$323,858
R01 · FY2022 · CA · contact PI
The Hippo Signaling Pathway in High Grade Serous Ovarian Carcinoma$323,281
R01 · FY2021 · CA · contact PI
The Hippo/Yap Signaling Pathway In Ovarian High Grade Serous Carcinoma$376,117
R01 · FY2020 · CA · contact PI
Novel Mechanisms of Cervical Cancer Development and Progression$370,543
R01 · FY2020 · CA · contact PI
The Hippo/Yap Signaling Pathway In Ovarian High Grade Serous Carcinoma$467,390
R01 · FY2019 · CA · contact PI
Novel Mechanisms of Cervical Cancer Development and Progression$359,426
R01 · FY2019 · CA · contact PI
The Hippo/Yap Signaling Pathway In Ovarian High Grade Serous Carcinoma$376,067
R01 · FY2018 · CA · contact PI
Novel Mechanisms of Cervical Cancer Development and Progression$370,543
R01 · FY2018 · CA · contact PI
Human Papillomavirus in the Development of High Grade Serous Ovarian carcinoma$234,421
R01 · FY2018 · CA · contact PI
The Hippo/Yap Signaling Pathway In Ovarian High Grade Serous Carcinoma$230,035
R01 · FY2017 · CA · contact PI
Novel Mechanisms of Cervical Cancer Development and Progression$197,656
R01 · FY2017 · CA · contact PI
Novel Mechanisms of Cervical Cancer Development and Progression$171,693
R01 · FY2017 · CA · contact PI
The Hippo/YAP Signaling Pathway in Ovarian High Grade Serous Carcinoma$118,519
R01 · FY2017 · CA · contact PI
Novel Mechanisms of Cervical Cancer Development and Progression$353,123
R01 · FY2016 · CA · contact PI
The Hippo/YAP Signaling Pathway in Ovarian High Grade Serous Carcinoma$344,269
R01 · FY2016 · CA · contact PI
GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer$233,602
R00 · FY2014 · HD · contact PI
GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer$230,894
R00 · FY2013 · HD · contact PI
GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer$251,060
R00 · FY2012 · HD · contact PI
GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer$90,000
K99 · FY2011 · HD · contact PI
GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer$90,000
K99 · FY2010 · HD · contact PI